Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model
- 31 January 1980
- journal article
- research article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 16 (2), 239-251
- https://doi.org/10.1016/0014-2964(80)90156-5
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- The mode of action of the antitumour agent GP 48,989 in the ratEuropean Journal of Cancer (1965), 1979
- Estrogen Control of Progesterone Receptor in Human Breast Cancer: Role of Estradiol and Antiestrogen*Endocrinology, 1978
- Tamoxifen in advanced breast cancerCancer Treatment Reviews, 1978
- A MONOHYDROXYLATED METABOLITE OF TAMOXIFEN WITH POTENT ANTIOESTROGENIC ACTIVITYJournal of Endocrinology, 1977
- Fundamental Differences in the Action of Estrogens and Antiestrogens on the Uterus: Comparison Between Compounds with Similar Duration of Action12Endocrinology, 1977
- Effect of tamoxifen (ICI 46,474) on initiation and growth of DMBA-induced rat mammary carcinomataEuropean Journal of Cancer (1965), 1976
- TAMOXIFEN AS AN ANTI-TUMOUR AGENT: EFFECT ON OESTROGEN BINDINGJournal of Endocrinology, 1976
- ANTIOESTROGENS: A REVIEWClinical Endocrinology, 1975
- The effect of synthetic anti-oestrogens on the growth and biochemistry of rat mammary tumoursEuropean Journal of Cancer (1965), 1975
- The Metabolism of Tamoxifen (I.C.I. 46,474) Part I : In Laboratory AnimalsXenobiotica, 1973